Twinbeech Capital LP Vericel Corp Transaction History
Twinbeech Capital LP
- $4.95 Billion
- Q1 2025
A detailed history of Twinbeech Capital LP transactions in Vericel Corp stock. As of the latest transaction made, Twinbeech Capital LP holds 24,108 shares of VCEL stock, worth $960,944. This represents 0.02% of its overall portfolio holdings.
Number of Shares
24,108Holding current value
$960,944% of portfolio
0.02%Shares
3 transactions
Others Institutions Holding VCEL
# of Institutions
290Shares Held
53MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$321 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$139 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.88MShares$115 Million3.98% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$98.2 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$97.1 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.88B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...